Literature DB >> 24305974

Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.

C L Cove1, C M Albert, F Andreotti, L Badimon, I C Van Gelder, E M Hylek.   

Abstract

Atrial fibrillation (AF) is an independent risk factor for thromboembolism and stroke. Women with AF are at a higher overall risk for thromboembolic stroke when compared to men with AF. Recent evidence suggests that female sex, after adjusting for stroke risk profile and sex differences in utilisation of anticoagulation, is an independent stroke risk factor in AF. The inclusion of female sex has improved the accuracy of the CHADS2 stroke risk stratification schema (Congestive heart failure, Hypertension, Age 75 years or greater, Diabetes mellitus, and prior Stroke or TIA). The newly revised and validated schema, CHA2DS2-VASc, dichotomises age and incorporates female sex and vascular disease history. The pathophysiological mechanisms to explain this increased risk in women are not well understood. According to Virchow's triad, thrombosis that leads to stroke in AF should arise from three co-existing phenomena: structural abnormalities, blood stasis, and a hypercoagulable state. Herein, we explore the sex differences in the biological processes that lead to thrombus formation as applied to Virchow's Triad. The objective of this review is to describe the potential mechanisms behind the increased risk of stroke in AF associated with female sex.

Entities:  

Keywords:  Atrial fibrillation; anticoagulation; sex differences; stroke

Mesh:

Substances:

Year:  2013        PMID: 24305974     DOI: 10.1160/TH13-04-0347

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 2.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 3.  Epicardial Adipose Tissue and Cardiovascular Disease.

Authors:  Thierry H Le Jemtel; Rohan Samson; Karnika Ayinapudi; Twinkle Singh; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2019-04-05       Impact factor: 5.369

4.  Gender and atrial fibrillation: revisiting its role in integrated ABC pathway management.

Authors:  Eka Prasetya Budi Mulia
Journal:  Heart Vessels       Date:  2022-08-31       Impact factor: 1.814

Review 5.  Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.

Authors:  Charlotte J Bai; Nidhi Madan; Shaza Alshahrani; Neelum T Aggarwal; Annabelle Santos Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

Review 6.  Epidemiology, diagnosis, and management of atrial fibrillation in women.

Authors:  Daniela Poli; Emilia Antonucci
Journal:  Int J Womens Health       Date:  2015-06-11

Review 7.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

8.  Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry.

Authors:  A John Camm; Gabriele Accetta; Wael Al Mahmeed; Giuseppe Ambrosio; Samuel Z Goldhaber; Sylvia Haas; Petr Jansky; Gloria Kayani; Frank Misselwitz; Seil Oh; Ali Oto; Pekka Raatikainen; Jan Steffel; Martin van Eickels; Ajay K Kakkar
Journal:  BMJ Open       Date:  2017-03-06       Impact factor: 2.692

9.  Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke.

Authors:  Shaowei Jiang; Aihua Fei; Ya Peng; Jun Zhang; You-Ran Lu; Hai-Rong Wang; Miao Chen; Shuming Pan
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

10.  Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.

Authors:  Yu-Chiang Hung; Yu-Chen Cheng; Chih-Hsin Muo; Hsienhsueh Elley Chiu; Chun-Ting Liu; Wen-Long Hu
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.